River Stone Overview
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
1
River Stone General Information
Description
Owner and operator of an integrated synthetic biology company intended to improve the production and performance of pharmaceuticals. The company focuses on areas such as molecules from synthetic chemistry, manufacturing processes, tissue targeting, tissue absorption, and related regions, enabling clients to produce affordable, higher-purity, and specific enantiomers.
Contact Information
Website
www.riverstonebio.comCorporate Office
- 251 Little Falls Drive
- Wilmington County of New Castle
- New Castle, DE 19808
- United States
Corporate Office
- 251 Little Falls Drive
- Wilmington County of New Castle
- New Castle, DE 19808
- United States
River Stone Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | Completed | Generating Revenue | ||||
| 2. Secondary Transaction - Private | 01-May-2017 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 01-Mar-2015 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
River Stone Patents
River Stone Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026180695-A1 | Method for producing noroxymorphone and bioactive derivatives thereof | Pending | 28-Feb-2025 | ||
| WO-2026099311-A2 | Microbial cell factories producing prostaglandins | Pending | 05-Nov-2024 | ||
| WO-2026099311-A3 | Microbial cell factories producing prostaglandins | Pending | 05-Nov-2024 | ||
| AU-2024216696-A1 | Improved synthesis of buprenorphine, analogues and intermediates | Pending | 08-Feb-2023 | ||
| EP-4662216-A1 | Improved synthesis of buprenorphine, analogues and intermediates | Pending | 08-Feb-2023 | C07D489/04 |
River Stone Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Double Bioventures | Venture Capital | Minority |
River Stone FAQs
-
Where is River Stone headquartered?
River Stone is headquartered in New Castle, DE.
-
What industry is River Stone in?
River Stone’s primary industry is Specialty Chemicals.
-
Is River Stone a private or public company?
River Stone is a Private company.
-
What is River Stone’s current revenue?
The current revenue for River Stone is .
-
Who are River Stone’s investors?
Double Bioventures has invested in River Stone.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process